Interleukin-10 modulates proinflammatory cytokines in the human monocytic cell line THP-1 stimulated with Borrelia burgdorferi lipoproteins

Infection and Immunity

Volumn 68, Issue 12, 2000, Pages 6663-6669

  Murthy, P K ^a,b   Dennis, Vida A ^a   Lasater, Barbara L ^a   Philipp, Mario T ^a  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BORRELIA BURGDORFERI; BORRELIA INFECTION; CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNITY; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; SPIROCHETE; STATISTICAL ANALYSIS;

ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BORRELIA BURGDORFERI GROUP; CELL LINE; CYTOKINES; HUMANS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; LIPOPROTEINS; LYME DISEASE VACCINES; MONOCYTES;

EID: 0034442793     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.12.6663-6669.2000     Document Type: Article

References (69)

1. Abraham, S. N., and M. Arock. 1998. Mast cells and basophils in innate immunity. Semin. Immunol. 18:373-381.
2. Akins, D. R., B. K. Purcell, M. Mitra, M. V. Norgard, and J. D. Radolf. 1993 Lipid modification of the 17-kilodalton membrane immunogen of Treponema pallidum determines macrophage activation as well as amphiphilicity. Infect. Immun. 61:1202-1210.
3. Arend, P. M., and J. M. Dayer. 1995. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor-α in rheumatoid arthritis. Arthritis Rheum. 38:151-160.
4. Asadullah, K., W. Sterry, K. Stephanek, D. Jasulaitis, M. Leopold, H. Audring, H. D. Volk, and W. D. Docke. 1998. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J. Clin. Invest. 101:783-794.
5. Barthold, S. W., D. H. Persing, A. L. Armstrong, and R. A. Peeples. 1991. Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am. J. Pathol. 139:263-273.
6. Barthold, S. W., E. Fikrig, L. K. Bockenstedt, and D. H. Persing. 1995. Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi. Infect. Immun. 63:2255-2261.
7. Bemelmans, M. H., L. J. van Tits, and W. A. Buurman. 1996. Tumor necrosis factor: function release and clearance. Crit. Rev. Immunol. 16:1-11.
8. Beutler, B. 2000. Tlr4: central component of the sole mammalian LPS sensor. Curr. Opin. Immunol. 12:20-26.
9. Bjornberg, F., M. Lantz, I. Olsson, and U. Gullberg. 1994. Mechanisms involved in the processing of the p55 and the p75 tumor necrosis factor (TNF) receptors to soluble receptor forms. Lymphokine Cytokine Res. 13: 203-211.
10. Brassard, M., and S. K. Wikel. 1997. Immunology of interactions between ticks and hosts. Med. Vet. Entomol. 11:270-276.
11. Brown, J. P., J. F. Zachary, C. Teuscher, J. J. Weis, and M. Woolen. 1999. Dual role of interleukin 10 in murine Lyme disease: regulation of arthritis severity and host defense. Infect. Immun. 67:5142-5150.
12. Burgdorfer, W. A., G. Barbour, S. F. Hayes, J. L Benach, E. Grunwaldt, and J. P. Davis. 1982. Lyme disease: a tick-borne spirochetosis? Science 216: 1317-1319.
13. Casey, L. C., R. A. Balk, and R. C. Bone. 1993. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119:771-778.
14. Cassatella, M. A., L. Meda, A. Bonora, M. Ceska, and G. Constantin. 1993. Interleukin-10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med. 178:2207-2211.
15. Coyle, P. K. 1993. Lyme disease, p. 179-183. In S. Manning (ed.), Pathogenesis of lyme disease. Mosby Year Book Co., St. Louis, Mo.
16. Dayer, J. M., B. De Rochemonteix, B. Burrus, S. Demczuk, and C. A. Dinarello. 1986. Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J. Clin. Invest. 77:645-648.
17. Defosse, D. L., and R. C. Johnson. 1992. In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi. Infect. Immun. 60:1109-1113.
18. de Silva, A. M., S. R. Telford 3rd, L. R. Brunet, S. W. Barthold, and E. Fikrig. 1996. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J. Exp. Med. 183:271-275.
19. de Waal Malefyt, R., J. Abrams, B. Bennett, C. Figdor, and J. E. de Vries. 1991. Interleukin-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209-1220.
20. England, J. D., R. P. Bohm, Jr., E. D. Roberts, and M. T. Philipp. 1997. Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease. Ann. Neurol. 1:375-384
21. Evequoz, V., F. Bettens, F. Kristensen, U. Trechsel, B. M. Stadler, J. M. Dayer, A. L. De Weck, and H. Fleisch. 1984. Interleukin 2-independent stimulation of rabbit chondrocyte collagenase and prostaglandin E2 production by an interleukin 1-like factor. Eur. J. Immunol. 14:490-495.
22. Ferreira, B. R., and J. S. Silva. 1998. Saliva of Rhipicephalus sanguineus tick impairs T cell proliferation and IFN-gamma-induced macrophage microbicidal activity. Vet. Immunol. Immunopathol. 64:279-293.
23. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. H. Howard, and A. OíGarra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815-3822.
24. Fraser, C. M., S. Casjens, W. M. Huang, G. G. Sutton, R. Clayton, R. Lathigra, O. White, K. A. Ketchum, R. Dodson, E. K. Hickey, M. Gwinn, B. Dougherty, J. F. Tomb, R. D. Fleischmann, D. Richardson, J. Peterson, A. R. Kerlavage, J. Quackenbush, S. Salzberg, M. Hanson, R. van Vugt, N. Palmer, M. D. Adams, J. Gocayne, and J. C. Venter, et al. 1997. Genomic sequence of a Lyme disease spirochete, Borrelia burgdorferi. Nature 390:580-586.
25. Ganapamo, F., B. Rutti, and M. Brossard. 1996. Immunosuppression and cytokine production in mice infested with Ixodes ricinus ticks: a possible role of laminin and interleukin-10 on the in vitro responsiveness of lymphocytes to mitogens. Immunology 87:259-263.
26. Giambartolomei, G. H., V. A. Dennis, and M. T. Philipp. 1998. Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and rhesus monkeys. Infect. Immun. 66:2691-2697.
27. Giambartolomei, G. H., V. A. Dennis, and M. T. Philipp. 1999. Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14. Infect. Immun. 67:140-147.
28. Glaser, K. B., I. Pease, J. Li, and D. W. Morgan. 1999. Enhancement of the surface expression of tumor necrosis factor alpha (TNF-alpha) but not the p55 TNF-alpha receptor in the THP-1 monocytic cell line by matrix metalloprotease inhibitors. Biochem. Pharmacol. 57:291-302.
29. Gross, D. M., T. Forsthuber, M. Tary-Lehmann, C. Etling, K. Ito, Z. A. Nagy, J. A. Field, A. C. Steere, and B. T. Huber. 1998. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 281: 703-706.
30. Habicht, G. S., L. I. Katona, and J. L. Benach. 1991. Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6. J. Infect. Dis. 164:568-574.
31. Haupl, T., S. Landgraf, P. Netusil, N. Biller, C. Capiau, P. Desmons, P. Hauser, and G. R. Burmester. 1997. Activation of monocytes by three OspA vaccine candidates: lipoprotein OspA is a potent stimulator of monokines. FEMS Immunol. Med. Microbiol. 19:15-23.
32. Hemmer, B., B. Gran, Y. Zhao, A. Marques, J. Pascal, A. Tzou, T. Kondo, I. Cortese, B. Bielekova, S. E. Straus, H. F. McFarland, R. Houghten, R. Simon, C. Pinilla, and R. Martin. 1999. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat. Med. 5:1375-1382.
33. Hirschfeld, M., C. J. Kirschning, R. Schwandner, H. Wesche, J. H. Weis, R. M. Wooten, and J. J. Weis. 1999. Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J. Immunol. 163:2382-2386.
34. Joosten, L. A., E. LuhBberts, P. Durez, M. M. Helsen, M. J. Jacobs, M. Goldman, and W. B. van den Berg. 1997. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. 40:249-260.
35. Kenefick, K. B., L. C. I. Lim, J. D. Alder, J. L. Schmitz, C. J. Czuprynski, and R. F. Schell. 1993. Induction of interleukin-1 release by high- and low-passage isolates of Borrelia burgdorferi. J. Infect. Dis. 167:1086-1092.
36. Kitchens, R. L., and R. S. Munford. 1995. Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J. Biol. Chem. 270:9904-9910.
37. Kopecky, J., M. Kuthejlove, and J. Pechova. 1999. Salivary gland extract from Ixodes ricinus ticks inhibits production of interferon-gamma by the upregulation of interleukin-10. Parasite Immunol. 21:351-356.
38. Lahn, M., H. Kalataradi, P. Mittelstadt, E. Pflum, M. Vollmer, C. Cady, A. Mukasa, A. T. Vella, D. Ikle, R. Harbeck, R. O'Brien, and W. Born. 1998. Early preferential stimulation of gamma delta T cells by TNF-α. J. Immunol. 160:5221-5230.
39. Lien, E., T. J. Sellati, A. Yoshimura, T. H. Flo, G. Rawadi, R. W Finberg, J. D. Carroll, T. Espevik, R. R. Ingalls, J. D. Radolf, and D. T. Golenbock. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274:33419-33425.
40. Lore, K., A. Sonnerborg, A. L. Spetz, U. Anderson, and J. Anderson. 1998. Immunocytochemical detection of cytokines and chemokines in Langerhans cells and in vitro derived dendritic cells. J. Immunol. Methods 214:97-111.
41. Lubberts, E., L. A. Joosten, M. M. Helsen, and W. B. van den Berg. 1997. Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone. Cytokine 10:361-369.
42. Ma, Y., K. P. Seiler, K. Tai, L. Yang, M. Woods, and J. J. Weis. 1994. Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway. Infect. Immun. 62:3663-3671.
43. Ma, Y., and J. J Weis. 1993. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect. Immun. 61:3843-3853.
44. Moore, K., A. OíGarra, R. de Waal Malefyt, P. Vieira, and T. R. Mossman. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165-190.
45. Nancy, C. A., A. L. Meierovics, M. Belosesvic, and S. J. Green. 1991. Tumor necrosis factor-alpha: central regulatory cytokine of macrophage antimicrobial activities. Pathobiology 59:182-184.
46. Nocton, J. J., F. Dressler, B. J. Rutledge, P. N. Rys, D. H. Persing, and A. C. Steere. 1994. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N. Engl. J. Med. 30:229-234.
47. Norgard, M. V., L. L. Arndt, D. R. Akins, L. L. Cuetty, D. A. Harrrich, and J. D. Radolf. 1996. Activation of human monocytic cells by Treponema pallisum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NK-kappa B. Infect. Immun. 64:3845-3852.
48. Nussler, A. K., U. A. Wittel, N. C. Nussler, and H. G. Beger. 1999. Leukocytes, the Janus cells in inflammatory disease. Langenbecks Arch. Surg. 384:222-232.
49. Philipp, M. T. 1998. Studies on OspA: a source of new paradigms in Lyme disease research. Trends Microbiol. 6:44-47.
50. Philipp, M. T., and B. J. B. Johnson. 1994. Animal models of Lyme disease: pathogenesis and immunoprophylaxis. Trends Microbiol. 2:431-437.
51. Pohl-Koppe, A., K. E. Balashov, A. C. Steere, E. L. Logigian, and D. A. Hafler. 1998. Identification of a T cell subset capable of both IFN-γ and IL-10 secretion in patients with chronic Borrelia burgdorferi infection. J. Immunol. 160:1804-1810.
52. Radolf, J. D., L. L. Arndt, D. R. Akins, L. L. Curetty, M. E. Levi, Y. Shen, L. S. Davis, and M. V. Norgard. 1995. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J. Immunol. 154:2865-2877.
53. Radolf, J. D., M. V. Norgard, M. E. Brandt, R. D. Isaacs, P. A. Thompson, and B. Beutler. 1991. Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis. Analysis using a CAT reporter construct. J. Immunol. 147:1968-1974.
54. Schoeler, G. B., S. A. Manweiler, and S. K. Wikel. 2000. Cytokine responses of C3H/HeN mice infested with Ixodes scapularis or Ixodes pacificus nymphs. Parasite Immunol. 22:31-40.
55. Schoeler, G. B., S. A. Manweiler, and S. K. Wikel. 1999. Ixodes scapularis: effects of repeated infestations with pathogen-free nymphs on macrophage and T lymphocyte cytokine responses of BALB/c and C3H/HeN mice. Exp. Parasitol. 92:239-248.
56. Sellati, T. J., D. A. Bouis, M. J. Caimano, J. A. Feulner, C. Ayers, E. Lien, and J. D. Radolf. 1999. Activation of human monocytic cells by Borrelia burgdorferi and Treponema pallidum is facilitated by CD14 and correlates with surface exposure of spirochetal lipoproteins. J. Immunol. 163:2049-2056.
57. Sellati, T. J., D. A Bouis, R. L. Kitchens, R. P. Darveau, J. Pugin, R. J. Ulevitch, S. C. Gangloff, S. M. Goyert, M. V. Norgard, and J. D. Radolf. 1998. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide. J. Immunol. 160:5455-5464.
58. Sigal, L. H. 1997. Lyme disease: a review of aspects of its immunology and immunopathogenesis. Annu. Rev. Immunol. 15:63-92.
59. Steere, A. C. 1989. Lyme disease. N. Engl. J. Med. 21:586-596.
60. Tai, K., Y. Ma, and J. J. Weis. 1994. Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA. Infect. Immun. 62:520-528.
61. Takemura, R., and Z. Werb. 1984. Secretory products of macrophages and their physiological functions. Am. J. Physiol. 246:C1-C9.
62. Tatro, J. B., L. I. Romero, D. Beasley, A. C. Steere, and S. Reichlin. 1994. Borrelia burgdorferi and Escherichia coli lipopolysaccharides induce nitric oxide and interleukin-6 production in cultured rat brain cells. J. Infect. Dis. 169:1014-1022.
63. Vassalli, P. 1992. The pathophysiology of tumor necrosis factor. Annu. Rev. Immunol. 10:411-452.
64. Waage, A., A. Halstensen, and T. Aspevik. 1987. Association between tumor necrosis factor in serum and facal outcome in patients with meningococcal disease. Lancet i:355-357.
65. Wanidworanum, C., and W. Strobet. 1993. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J. Immunol. 151: 6853-6861.
66. Wooten, R. M., T. B. Morrison, J. H. Weis, S. D. Wright, R. Thieringer, and J. J. Weis. 1998. The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J. Immunol. 160:5485-5492.
67. Yang, L. J., H. Weis, E. Eichwald, C. P. Kolbert, D. H. Persing, and J. J. Weis. 1994. Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect. Immun. 62:492-500.
68. Yin, Z., J. Braun, L. Neure, P. Wu, U. Eggens, A. Krause, T. Kamradt, and J. Sieper. 1997. T cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines. Arthritis Rheumatism 40:66-79.
69. Zeidner, N., M. L. Mbow, M. Dolan, R. Massung, E. Baca, and J. Piesman. 1997. Effects of Ixodes scapularis and Borrelia burgdorferi on modulation of the host immune response: induction of a TH2 cytokine response in Lyme disease-susceptible (C3H/HeJ) mice but not in disease-resistant (BALB/c) mice. Infect. Immun. 65:3100-3106.